X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (16619) 16619
Newspaper Article (1116) 1116
Book Chapter (111) 111
Dissertation (108) 108
Web Resource (73) 73
Magazine Article (72) 72
Book / eBook (44) 44
Government Document (31) 31
Conference Proceeding (20) 20
Trade Publication Article (16) 16
Publication (12) 12
Streaming Video (11) 11
Report (4) 4
Book Review (3) 3
Newsletter (3) 3
Journal / eJournal (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10892) 10892
tuberculosis (6014) 6014
infectious diseases (5095) 5095
drug resistance (4299) 4299
female (4161) 4161
male (4156) 4156
tuberculosis, multidrug-resistant - drug therapy (3802) 3802
adult (3480) 3480
microbiology (3286) 3286
antitubercular agents - therapeutic use (3270) 3270
mycobacterium tuberculosis - drug effects (3048) 3048
multidrug-resistant (3042) 3042
multidrug resistant organisms (2806) 2806
middle aged (2780) 2780
tuberculosis, multidrug-resistant - epidemiology (2721) 2721
multidrug-resistant tuberculosis (2433) 2433
microbial sensitivity tests (2384) 2384
tuberculosis, multidrug-resistant - microbiology (2100) 2100
drug resistance in microorganisms (2084) 2084
respiratory system (2041) 2041
antitubercular agents - pharmacology (1976) 1976
mycobacterium-tuberculosis (1946) 1946
pharmacology & pharmacy (1876) 1876
infections (1857) 1857
bacteria (1847) 1847
antibiotics (1820) 1820
mycobacterium tuberculosis (1778) 1778
epidemiology (1744) 1744
mycobacterium tuberculosis - isolation & purification (1696) 1696
adolescent (1670) 1670
aged (1658) 1658
risk factors (1596) 1596
mycobacterium tuberculosis - genetics (1595) 1595
tuberculosis, multidrug-resistant - diagnosis (1578) 1578
prevalence (1528) 1528
drug resistance, multiple, bacterial (1517) 1517
research (1500) 1500
treatment outcome (1404) 1404
pulmonary tuberculosis (1361) 1361
tuberculosis, pulmonary - drug therapy (1359) 1359
immunology (1311) 1311
animals (1270) 1270
young adult (1261) 1261
medicine (1213) 1213
retrospective studies (1173) 1173
medicine, general & internal (1163) 1163
public health (1150) 1150
child (1124) 1124
drug therapy (1120) 1120
anti-bacterial agents - pharmacology (1112) 1112
health aspects (1103) 1103
patients (1088) 1088
diagnosis (1067) 1067
analysis (1040) 1040
mortality (1001) 1001
tuberculosis - drug therapy (981) 981
mutation (930) 930
drug resistance, bacterial (920) 920
antimicrobial agents (899) 899
hospitals (893) 893
care and treatment (889) 889
antitubercular agents (888) 888
research article (883) 883
rifampin (877) 877
multidrug resistance (872) 872
infection (865) 865
antimicrobial resistance (862) 862
tuberculosis - epidemiology (848) 848
tuberculosis, pulmonary - epidemiology (805) 805
public, environmental & occupational health (803) 803
hiv (796) 796
drug-resistance (787) 787
genotype (764) 764
antitubercular agents - administration & dosage (761) 761
strains (753) 753
anti-bacterial agents - therapeutic use (746) 746
tuberculosis, pulmonary - microbiology (744) 744
tuberculosis, multidrug-resistant - prevention & control (735) 735
incidence (713) 713
surveillance (709) 709
child, preschool (708) 708
sputum - microbiology (708) 708
risk-factors (707) 707
drugs (700) 700
multidrug resistant (695) 695
infectious disease (692) 692
mdr-tb (671) 671
aged, 80 and over (657) 657
drug therapy, combination (656) 656
bacterial infections (649) 649
rifampin - pharmacology (635) 635
multidisciplinary sciences (617) 617
pathogens (608) 608
laboratories (600) 600
multidrug resistant tuberculosis (599) 599
tuberculosis, multidrug-resistant (596) 596
studies (590) 590
nosocomial infections (588) 588
transmission (588) 588
escherichia-coli (583) 583
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (40) 40
Gerstein Science - Stacks (23) 23
West Park Healthcare Centre - Stacks (8) 8
Robarts - Government Pubs (3) 3
Scarborough Hospital - Online (3) 3
UofT at Mississauga - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Media Commons - Microtexts (1) 1
St. Michael's Hospital - Stacks (1) 1
University College (Laidlaw) - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (17000) 17000
French (334) 334
Spanish (295) 295
Portuguese (268) 268
Japanese (215) 215
German (195) 195
Russian (181) 181
Chinese (142) 142
Korean (71) 71
Italian (36) 36
Turkish (30) 30
Polish (26) 26
Romanian (23) 23
Czech (16) 16
Dutch (14) 14
Swedish (14) 14
Ukrainian (13) 13
Norwegian (11) 11
Danish (9) 9
Hungarian (6) 6
Croatian (5) 5
Lithuanian (5) 5
Bosnian (4) 4
Finnish (4) 4
Persian (4) 4
Serbian (4) 4
Arabic (3) 3
Indonesian (2) 2
Slovak (2) 2
Galician (1) 1
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BMC health services research, ISSN 1472-6963, 2017, Volume 17, Issue 1, pp. 249 - 9
Journal Article
Nature genetics, ISSN 1546-1718, 2015, Volume 47, Issue 3, pp. 242 - 249
Journal Article
Emerging infectious diseases, ISSN 1080-6059, 2015, Volume 21, Issue 3, pp. 409 - 416
Journal Article
Indian journal of medical research (New Delhi, India : 1994), ISSN 0971-5916, 08/2017, Volume 145, Issue March, pp. 271 - 293
Emergence of extensively drug-resistant tuberculosis (XDR-TB) has significantly threatened to jeopardize global efforts to control TB, especially in HIV... 
Line drugs | Pregnancy | Multidrug | Resistant tuberculosis | HIV | Second | Diagnosis | XDR-TB | Epidemiology | Extensively drug | India | MYCOBACTERIUM-TUBERCULOSIS | MEDICINE, RESEARCH & EXPERIMENTAL | MULTIDRUG-RESISTANT | RISK-FACTORS | TREATMENT OUTCOMES | pregnancy | MDR-TB | multidrug-resistant tuberculosis | IMMUNOLOGY | CLINICAL MANAGEMENT | epidemiology | MEDICINE, GENERAL & INTERNAL | extensively drug resistant tuberculosis | IMPACT | SURVEILLANCE | RUSSIA | second-line drugs | HIV Infections - epidemiology | HIV Infections - virology | Humans | Risk Factors | India - epidemiology | HIV - pathogenicity | Tuberculosis, Multidrug-Resistant - epidemiology | Tuberculosis, Multidrug-Resistant - diagnosis | Mycobacterium tuberculosis - pathogenicity | HIV Infections - microbiology | Tuberculosis, Multidrug-Resistant - microbiology | HIV Infections - complications | Tuberculosis, Multidrug-Resistant - therapy | Drug resistance in microorganisms | Public health administration | Forecasts and trends | Tuberculosis | Drug therapy | Epidemics | Chemotherapy | Surveillance | Medical laboratories | Mortality | Drug resistance | Patients | extensively drug-resistant tuberculosis | multidrug-resistant tuberculosis-pregnancy | Review | Diagnosis - epidemiology - extensively drug-resistant tuberculosis - HIV - India - multidrug-resistant tuberculosis -pregnancy - second-line drugs - XDR-TB
Journal Article
The international journal of tuberculosis and lung disease, ISSN 1027-3719, 09/2014, Volume 18, Issue 9, pp. 1019 - 1025
BACKGROUND: Effective treatment for drug-susceptible tuberculosis (TB) rapidly renders patients noninfectious, long before conversion of sputum acid-fast smear... 
Impact of treatment | Multidrug-resistant tuberculosis | Extensively drug-resistant tuberculosis | Transmission | MYCOBACTERIUM-TUBERCULOSIS | VARIABILITY | TUBERCLE-BACILLI | INFECTIOUS DISEASES | transmission | impact of treatment | RESPIRATORY SYSTEM | extensively drug-resistant tuberculosis | multidrug-resistant tuberculosis | INFECTION | Sputum - microbiology | Tuberculosis, Pulmonary - microbiology | Air Microbiology | Humans | Middle Aged | Male | Tuberculosis, Pulmonary - drug therapy | Infection Control - methods | Mycobacterium tuberculosis - drug effects | Tuberculin Test | Tuberculosis, Multidrug-Resistant - diagnosis | Cross Infection - transmission | Microbial Sensitivity Tests | Young Adult | Time Factors | Tuberculosis, Multidrug-Resistant - microbiology | Tuberculosis, Multidrug-Resistant - transmission | Adult | Extensively Drug-Resistant Tuberculosis - microbiology | Female | Retrospective Studies | Antitubercular Agents - therapeutic use | Extensively Drug-Resistant Tuberculosis - drug therapy | Guinea Pigs | Cross Infection - prevention & control | Treatment Outcome | Mycobacterium tuberculosis - isolation & purification | Animals | Extensively Drug-Resistant Tuberculosis - transmission | Tuberculosis, Pulmonary - diagnosis | Cross Infection - microbiology | Adolescent | Cross Infection - diagnosis | Aged | Tuberculosis, Pulmonary - transmission | Tuberculosis, Multidrug-Resistant - drug therapy
Journal Article
Trials, ISSN 1745-6215, 06/2013, Volume 14, Issue 1, pp. 170 - 170
Background: Tuberculosis control in sub-Saharan Africa has long been hampered by poor diagnostics and weak health systems. New molecular diagnostics, such as... 
Point-of-care systems | Clinical trial | Molecular diagnostics | Multidrug-resistant tuberculosis | Tuberculosis | HIV | MEDICINE, RESEARCH & EXPERIMENTAL | OF-CARE DIAGNOSIS | FEASIBILITY | LABORATORY DIAGNOSIS | IMPLEMENTATION | XPERT MTB/RIF | TREATMENT INITIATION | RESISTANT TUBERCULOSIS | RIFAMPIN RESISTANCE | POINT | POSITIVE PULMONARY TUBERCULOSIS | Sputum - microbiology | Predictive Value of Tests | Tuberculosis, Pulmonary - microbiology | Coinfection | Laboratories | Humans | Clinical Protocols | Tuberculosis, Pulmonary - drug therapy | Tuberculosis, Multidrug-Resistant - diagnosis | Molecular Diagnostic Techniques | Time Factors | Tuberculosis, Multidrug-Resistant - microbiology | Bacteriological Techniques | HIV Infections - mortality | Antitubercular Agents - therapeutic use | Tuberculosis, Multidrug-Resistant - mortality | Risk Assessment | Risk Factors | South Africa - epidemiology | Logistic Models | Mycobacterium tuberculosis - isolation & purification | Point-of-Care Systems | Tuberculosis, Pulmonary - mortality | Tuberculosis, Pulmonary - diagnosis | Ambulatory Care Facilities | Primary Health Care | Research Design | Mycobacterium tuberculosis - growth & development | Rural Health Services | Tuberculosis, Multidrug-Resistant - drug therapy | Virus diseases | Epidemics | Drug resistance in microorganisms | South Africa | HIV (Viruses) | HIV infection
Journal Article
PLoS medicine, ISSN 1549-1676, 2018, Volume 15, Issue 7, p. e1002591
Background An estimated 32,000 children develop multidrug-resistant tuberculosis (MDR-TB; Mycobacterium tuberculosis resistant to isoniazid and rifampin) each... 
SOUTH-AFRICA | MEDICATIONS | MANAGEMENT | INITIATION | DISEASE | PULMONARY TUBERCULOSIS | ANTIRETROVIRAL THERAPY | INFECTED CHILDREN | YOUNG-CHILDREN | INTRATHORACIC TUBERCULOSIS | MEDICINE, GENERAL & INTERNAL | TRENDS | Antitubercular Agents - adverse effects | Coinfection | HIV Infections - epidemiology | Humans | Child, Preschool | Male | Tuberculosis, Multidrug-Resistant - diagnosis | Child Nutrition Disorders - physiopathology | Tuberculosis, Multidrug-Resistant - microbiology | Malnutrition - epidemiology | Anti-HIV Agents - therapeutic use | Female | Nutritional Status | Child | Antitubercular Agents - therapeutic use | Severity of Illness Index | Risk Assessment | Comorbidity | Child Nutritional Physiological Phenomena | Risk Factors | Treatment Outcome | Child Nutrition Disorders - epidemiology | Malnutrition - physiopathology | Tuberculosis, Multidrug-Resistant - epidemiology | Adolescent | Age of Onset | HIV Infections - drug therapy | Tuberculosis, Multidrug-Resistant - drug therapy | Drug resistance in microorganisms | Care and treatment | Patient outcomes | Research | Children | Pediatric research | Diseases | Meta-analysis | Health sciences | Therapy | Pediatrics | Chest | Sexually transmitted diseases--STD | Laboratories | Health services | Childrens health | Systematic review | Infections | Drug resistance | Confidence intervals | Demographics | Antiretroviral agents | Human immunodeficiency virus--HIV | Malnutrition | Drug therapy | Isoniazid | Public health | Medical research | Data analysis | Statistical analysis | Tutu, Desmond | Data processing | Regression analysis | Patients | Disease control | Antiretroviral therapy | Children & youth | Medicine | Multidrug resistant organisms | Hospitals | Tuberculosis | Infectious diseases | Womens health | Rifampin | STD | Sexually transmitted diseases | HIV | Human immunodeficiency virus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2014, Volume 371, Issue 8, pp. 723 - 732
Journal Article
PloS one, ISSN 1932-6203, 2015, Volume 10, Issue 3, pp. e0119332 - e0119332
Journal Article
PLoS medicine, ISSN 1549-1676, 2011, Volume 8, Issue 7, p. e1001067
Journal Article
American journal of respiratory and critical care medicine, ISSN 1535-4970, 2019, Volume 200, Issue 10, pp. e93 - e142
Journal Article